Skip to content
AnalystLens

Labcorp Holdings 8-K Report, Regulation FD Disclosure (May 8, 2024)

Reports
Regulation FD·Exhibits & Filings
Filing Date
Filed May 8, 2024
Period End
May 8, 2024
Security
LH
In the record · 2016–202610-K1310-Q338-K382

LH filed 13 annual reports (10-K), 33 quarterly reports (10-Q) and 382 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Sep ’17Sep ’17
  2. Auditor change8-K · Nov ’20Nov ’20
  3. Leadership change8-K · Oct ’22Oct ’22
  4. Leadership change8-K · Aug ’26Aug ’26

Summary

Summary of the 8-K filed May 8, 2024. Cited figures are marked; the original filing is the authoritative source.

Laboratory Corporation of America Holdings (Labcorp, NYSE: LH) filed this Current Report on Form 8-K dated May 8, 2024 to furnish a Regulation FD disclosure.

The company announced that its Annual Meeting of Shareholders will be webcast live on May 14, 2024 at 9:00 a.m. ET, viewable on the Labcorp Investor Relations website, with an archived replay available for one year. The filing contains no financial results, guidance, or transaction details.

The press release attached as Exhibit 99.1 describes Labcorp as a global leader in laboratory services and states that the company has more than 67,000 employees serving clients in over 100 countries. It also says Labcorp worked on over 84%a of the new drugs approved by the FDA in 2023 and performed more than 600 million tests for patients worldwide.

For investors, this filing is administrative in nature. Its main value is in confirming the date and access method for the annual shareholder meeting, rather than in signaling any change in operations, financial condition, or strategy.

Key Highlights

  1. Labcorp will webcast its Annual Meeting of Shareholders live on May 14, 2024 at 9:00 a.m. ET.
  2. The webcast can be viewed online on the Labcorp Investor Relations website.
  3. An archived replay of the webcast will be available for one year.
  4. The filing is a Regulation FD disclosure under Item 7.01 and contains no financial results or guidance.
  5. Exhibit 99.1 is a press release dated May 8, 2024 announcing the webcast.
  6. The press release states Labcorp has more than 67,000 employees and serves clients in over 100 countries.
  7. The press release states Labcorp worked on over 84% of new FDA-approved drugs in 2023 and performed more than 600 million tests.

Frequently Asked Questions

  1. When and how can shareholders view the 2024 Annual Meeting?

    The Annual Meeting of Shareholders will be webcast live on May 14, 2024 at 9:00 a.m. ET. It can be viewed online through the Labcorp Investor Relations website.

  2. Is an archived version of the meeting available?

    Yes. The filing states that an archived replay of the webcast will be available for one year.

  3. Does this filing report any financial results or new business developments?

    No. The filing is a Regulation FD disclosure about the annual meeting webcast and does not include financial results, guidance, or transaction information.

  4. What does the attached press release say about Labcorp's scale?

    The press release states that Labcorp has more than 67,000 employees, serves clients in over 100 countries, worked on over 84% of the new drugs approved by the FDA in 2023, and performed more than 600 million tests for patients worldwide.